TETRAHYDROCANNABINOL - FROM POT TO PRESCRIPTION

被引:13
作者
LASZLO, J
机构
关键词
D O I
10.7326/0003-4819-91-6-916
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our group recently studied 41 patients with cancer who were selected as being refractory to aggressive standard antiemetic agents and treated with one or more courses of THC. We found suprisingly good results in more than two thirds of the patients, surprising in that many patients were already preconditioned for emesis by their prior chemotherapy experience. To summarize, we can safely conclude that cannabinoids (of which THC is currently the only viable candidate) clearly have a salutory effect on drug-induced nausea and vomiting.
引用
收藏
页码:916 / 918
页数:3
相关论文
共 9 条
[1]  
CARROLL L, ALICE WONDERLAND, P134
[2]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].
CHANG, AE ;
SHILING, DJ ;
STILLMAN, RC ;
GOLDBERG, NH ;
SEIPP, CA ;
BAROFSKY, I ;
SIMON, RM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824
[3]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC FOR PATIENTS RECEIVING CANCER-CHEMOTHERAPY - COMPARISON WITH PROCHLORPERAZINE AND A PLACEBO [J].
FRYTAK, S ;
MOERTEL, CG ;
OFALLON, JR ;
RUBIN, J ;
CREAGAN, ET ;
OCONNELL, MJ ;
SCHUTT, AJ ;
SCHWARTAU, NW .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :825-830
[4]   SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTI-EMETIC IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].
HERMAN, TS ;
EINHORN, LH ;
JONES, SE ;
NAGY, C ;
CHESTER, AB ;
DEAN, JC ;
FURNAS, B ;
WILLIAMS, SD ;
LEIGH, SA ;
DORR, RT ;
MOON, TE .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (23) :1295-1297
[5]  
LUCAS S, JAMA
[6]  
NIGHTINGALE SL, 1979, JAMA-J AM MED ASSOC, V241, P373
[7]  
REGELSON W, 1976, PHARMACOLOGY MARIHUA
[8]   ANTIEMETIC EFFECT OF DELTA-9-TETRAHYDROCANNABINOL IN PATIENTS RECEIVING CANCER CHEMOTHERAPY [J].
SALLAN, SE ;
ZINBERG, NE ;
FREI, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (16) :795-797
[9]  
1979, FED REG 36123, V44